期刊文献+

ELISA法检测人微小B19抗体及其临床应用评价

Clinical value of measuring human parvovirus B19 antibody by ELISA
下载PDF
导出
摘要 目的建立检测人微小病毒B19的间接酶联免疫吸附(ELISA)法,评价其临床应用价值。方法采用原保存的XA-B19 VP1独特区蛋白包被ELISA板,优化该方法检测B19抗体的最佳实验条件。与聚合酶链反应(PCR)、parvovirus B19 ELISA方法进行比较,评价其一致性。结果最佳包被量为25 ng/孔,标本血清最佳稀释倍数为1∶200。建立的间接ELISA检测体系与腺病毒、呼吸道合胞病毒、流感病毒、副流感病毒、疱疹病毒抗体阳性血清无交叉反应。其检测B19 IgM敏感性为88.37%,特异性为96.15%,与PCR方法一致性好(kappa值>0.75,P>0.05);与parvovirus B19 IgM ELISA方法符合性好,符合率为96.8%。与parvovirus B19IgG ELISA方法比较kappa值>0.75,P>0.05,两种检测方法一致性好。结论建立的间接ELISA检测B19抗体的方法具有灵敏度高、特异性强、经济、快速、方便等优点,适合于流行病学调查和临床标本检测。 Objectives To establish indirect enzyme linked immunosorbent assay (ELISA) method for detection of human parvovirus B19 antibody and evaluate its importance for clinical application. Methods Specific B19 antibodies were detected with indirect ELISA. The method was further optimized by coating ELISA plate with XA-B19 VP1 unique recombinant protein. Comparison among this indirect ELISA method, polymerase chain reaction (PCR) and parvovirus B19 IgG, IgM ELISA kit (Germany) was done, and the consistency among these three methods was assessed as well. Results The optimal concentration of coated antigen VP1 unique recombinant protein was 25 ng per well and the optimal serum dilution was 1:200. This indirect ELISA system has no cross-reaction with the serum antibodies of adenovirus, respiratory syncitial virus, influenza virus, parainfluenza virus, and human herpes virus. The sensitivity was 88.37% and the specificity was 96.15% when it was used to detect B19 IgM. The concordance between the indirect ELISA method and PCR was good (kappa 〉 0.75, P 〉 0.05). The concordance between the indirect ELISA method and parvovirus B19 IgM ELISA kit was also good. When it was used to detect B19 IgG, the concordance between the indirect ELISA method and parvovirus B19 IgG ELISA kit was good (kappa 〉 0.75, P 〉 0.05). Conclusions Indirect ELISA is sensitive, specific, economical, quick and convenient for detection of antibodyagainst parvovirus B19 and it is suitable for clinical use.
出处 《临床儿科杂志》 CAS CSCD 北大核心 2008年第6期464-466,479,共4页 Journal of Clinical Pediatrics
基金 国家自然科学基金资助项目(No.30571948)
关键词 人微小病毒B19 VP1独特区蛋白 酶联免疫吸附法 human parvovirus B 19 VP1 unique protein enzyme linked immunosorbent assay polymerase chain reaction
  • 相关文献

参考文献12

  • 1Asian B, Serin MS, Aslaci G, et al. Detection of parvovirus B19 in synovial fluids of patients with osteoarthritis [J]. Diagn Microbiol Infect Dis,2008,60 (4) :381-385.
  • 2Dina J, Vabret A, Rambaud C, et al. Fulminant myocarditis associated with parvovirus B19 infection in a child [J]. J Clin Virol,2008,42( 1 ):70-71.
  • 3Dennert R, Schalla S, Suylen RJ, et al. Giant cell myocarditis triggered by a parvovirus B19 infection [J]. Int J Cardiol, 2008,14( 1 ) :33-41.
  • 4Roubille F, Roubille C, Rullier P, et al. Daily management of acute periearditis:elinieal and paraelinieal outcomes,etiologlcal diagnosis (Paris) [J]. Ann Cardiol Angeiol, 2008,57 ( 1 ) : 1-9[French].
  • 5张国成,苏国平,孙新,许东亮,陈彩平,汤雪晴,Biao LI.我国再障患儿血清中人细小病毒B19 NS基因序列测定及变异分析(英文)[J].中国当代儿科杂志,2003,5(1):5-7. 被引量:3
  • 6张国成,许东亮,王晓明,张笑飞,钱新宏,郑跃杰,李飚.国人细小病毒B19感染相关疾病谱[J].第四军医大学学报,1999,20(6):495-498. 被引量:16
  • 7祝丙华,许金波.人细小病毒B19检测方法研究进展[J].国际病毒学杂志,2006,13(1):16-19. 被引量:5
  • 8李志宏,张国成,许东亮,李小青,孙新,丁翠玲.人微小病毒B19VP1独特区蛋白的表达及纯化[J].细胞与分子免疫学杂志,2007,23(4):372-373. 被引量:4
  • 9Sant'Anna AL,Garcia Rde C,Marzoche M,et al. Study of chronic hemolytic anemia patients in Rio de Janeiro: prevalence of anti-human parvovirus B19 IgG antibodies and the development aplastic crises [J]. Rev Inst Med Trop Sao Paulo,2002,44(4) : 187-190.
  • 10Florea AV, Ionescu DN, Melhem MF. Parvovirus B19 infection in the immunocompromised host [J]. Arch Pathol Lab Med,2007,131 (5) :799-804.

二级参考文献31

  • 1张国成,许东亮,李佐华,王瑞华,王绮云.聚合酶链反应检测人细小病毒B19-DNA[J].第四军医大学学报,1993,14(6):463-464. 被引量:4
  • 2张国成.儿童细小病毒B19感染[J].国外医学(儿科学分册),1994,21(5):257-260. 被引量:12
  • 3Heegaard ED,Brown KE.Human parvovirus B19.Clin Microbiol Rev.2002 Jul; 15(3):485-505.
  • 4Koppelman MH,Cuypers HT,Emrich T,Zaaijer HL.Quantitative real-time detection of parvovirus B19 DNA in plasma.Transfusion.2004 Jan;44(1):97-103.
  • 5Setubal S,Cardias CA,de Oliveira SA,do Nascimento JP.Viremic blood donor found by a rapid screening method in a season of high human parvovirus B19 activity in Niteroi,Rio de Janeiro,Brazil.Mem Inst Oswaldo Cruz.2004 Feb;99(1):95-99.
  • 6Caillet-Fauquet P,Di Giambattista M,Draps ML,Sandras F,Branckaert T,de Launoit Y,Laub R.Continuous-flow UVC irradiation:a new,effective,protein activity-preserving system for inactivating bacteria and viruses,including erythrovirus B19.J Virol Methods.2004 Jun 15;118(2):131-139.
  • 7E.Manarest,G.Gallinella,S.Venturoli,M.Zerbini,MonicaMusiani.Detection of parvovirus B19 IgG:choice of antigens and serological tests.Journal of Clinical Virology.2004 Jun 29(1):51-53.
  • 8Harder TC,Hufnagel M,Zahn K,Beutel K,Schmitt HJ,Ullmann U,Rautenberg P.New LightCycler PCR for rapid and sensitive quantification of parvovirus B19 DNA guides therapeutic decisionmaking in relapsing infections.J Clin Microbiol.2001 Dec; 39(12):4413-4419.
  • 9Brown KE,Young NS.Parvovirus B19 in human disease.Annu Rev Med.1997;48:59-67.
  • 10Flunker G,Peters A,Wiersbitzky S,Modrow S,Seidel W.Persistent parvovirus B19 infections in immunocompromised children.Med Microbiol Immunol (Berl).1998 Mar; 186(4):189-194.

共引文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部